Lead sponsor
Oregon Health and Science University
3 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
3
Trials led
0
Active
84
Total enrollment
3
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 4
1
Not applicable
2
Trials by status
Completed
2
Unknown
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Two Way Crossover Closed Loop Study Insulin vs Insulin and PramlintideHbA1c ≤10.5%not applicableCompleted33
A Study of the Functional Magnetic Resonance Imaging Response to Leptin and Pramlintide—not applicableUnknown10